HLA Janssen, M van Zonneveld, H Senturk, S … - The Lancet, 2005 - Elsevier 307 HBeAg-positive patients with chronic hepatitis B were assigned combination
therapy (100 μg/week pegylated interferon alfa-2b and 100 mg/day lamivudine) or
monotherapy (100 μg/week pegylated interferon alfa-2b and placebo) for 52 ... Cited by 429 - Related articles - All 5 versions
- ►shouxi.net P Marcellin, GKK Lau, F Bonino, P Farci, S … - The New England journal of medicine, 2004 - nejm.highwire.org From the Service d'Hépatologie, INSERM Unité 481 and Centre de Recherches
Claude Bernard sur les Hépatites Virales, Hôpital Beaujon, Clichy, France
(PM); Queen Mary Hospital, University of Hong Kong, Hong Kong, China ... Cited by 491 - Related articles - BL Direct - All 9 versions
[CITATION] A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing …
- ►angrylapdog.com GKK Lau, T Piratvisuth, KX Luo, P Marcellin, … - New England Journal of Medicine, 2005 - content.nejm.org From the Department of Medicine, Queen Mary Hospital, University of Hong Kong,
Hong Kong SAR, China (GKKL); the De- partment of Medicine, Songklanakarin Hos-
pital, Songkla, Thailand (TP); the Depart- ment of Infectious Diseases, ... Cited by 491 - Related articles - BL Direct - All 12 versions
HLY Chan, AY Hui, VWS Wong, AML Chim, ML … - Hepatology, 2005 - interscience.wiley.com We have previously demonstrated that combination peginterferon and lamivudine
treatment has superior antiviral efficacy to lamivudine monotherapy in chronic
hepatitis B. In this study, we investigated the long-term posttreatment ... Cited by 59 - Related articles - All 4 versions
WGE Cooksley, T Piratvisuth, SD Lee, V … - Journal of viral hepatitis, 2003 - medscape.com Current therapies for chronic hepatitis B (CHB) have a number of limitations,
and better treatment options are needed. Peginterferon -2a (40 kDa) is superior
to conventional interferon -2a in the treatment of chronic hepatitis C. ... Cited by 340 - Related articles - BL Direct - All 7 versions
- ►sebivo.com.ua [PDF] CL Lai, N Leung, EK Teo, M Tong, F Wong, … - Gastroenterology, 2005 - Elsevier Background & Aims: A previous 4-week trial of telbivudine in patients with
chronic hepatitis B indicated marked antiviral effects with good tolerability,
leading to the present 1-year phase 2b trial. Methods: This randomized, ... Cited by 269 - Related articles - All 5 versions
M van Zonneveld, P Honkoop, BE Hansen, … - Hepatology, 2004 - interscience.wiley.com Data on the long-term effects of interferon alfa (IFN) treatment on disease
progression and mortality in patients with chronic hepatitis B (CHB) are
limited. To evaluate factors that influence clinical outcome and survival, ... Cited by 164 - Related articles - All 5 versions
